United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 493.99 USD 1.12% Market Closed
Market Cap: 21.3B USD

Intrinsic Value

The intrinsic value of one UTHR stock under the Base Case scenario is hidden USD. Compared to the current market price of 493.99 USD, United Therapeutics Corp is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

UTHR Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
United Therapeutics Corp

Intrinsic Value History
Dive into the past to invest in the future

UTHR looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether UTHR usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about UTHR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is UTHR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for United Therapeutics Corp.

Explain Valuation
Compare UTHR to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Significant reliance on its pulmonary arterial hypertension (PAH) franchise exposes United Therapeutics to competition from newer therapies and potential generic entrants, which could erode its leading market share and pricing power.

Bull Theses

United Therapeutics has maintained a strong foothold in PAH treatments with established therapies such as Tyvaso, Orenitram, and Remodulin, supported by steady demand and favorable reimbursement, driving stable cash flow.

Show More Less
How do you feel about UTHR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
United Therapeutics Corp

Current Assets 3.5B
Cash & Short-Term Investments 2.8B
Receivables 297.7m
Other Current Assets 428.7m
Non-Current Assets 3.9B
Long-Term Investments 1.6B
PP&E 1.6B
Intangibles 116.7m
Other Non-Current Assets 617.5m
Current Liabilities 546.3m
Accounts Payable 468m
Other Current Liabilities 78.3m
Non-Current Liabilities 214.6m
Other Non-Current Liabilities 214.6m
Efficiency

Free Cash Flow Analysis
United Therapeutics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
United Therapeutics Corp

Revenue
3.1B USD
Cost of Revenue
-356.9m USD
Gross Profit
2.8B USD
Operating Expenses
-1.2B USD
Operating Income
1.5B USD
Other Expenses
-250.3m USD
Net Income
1.3B USD
Fundamental Scores

UTHR Profitability Score
Profitability Due Diligence

United Therapeutics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Operating Margin
Exceptional ROIC
Strong 3Y Average Operating Margin
hidden
Profitability
Score

United Therapeutics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

UTHR Solvency Score
Solvency Due Diligence

United Therapeutics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

United Therapeutics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

UTHR Price Targets Summary
United Therapeutics Corp

Wall Street analysts forecast UTHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UTHR is 520.16 USD with a low forecast of 414.53 USD and a high forecast of 630 USD.

Lowest
Price Target
414.53 USD
16% Downside
Average
Price Target
520.16 USD
5% Upside
Highest
Price Target
630 USD
28% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

United Therapeutics Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for UTHR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

UTHR Insider Trading
Buy and sell transactions by insiders

UTHR News

Other Videos
What is the Intrinsic Value of one UTHR stock?

The intrinsic value of one UTHR stock under the Base Case scenario is hidden USD.

Is UTHR stock undervalued or overvalued?

Compared to the current market price of 493.99 USD, United Therapeutics Corp is hidden .

Back to Top